安踏體育(02020.HK)擬議根據股份獎勵計劃購買股份
格隆匯11月24日丨安踏體育(02020.HK)發佈公吿,為配合與支持集團發展戰略,公司有意於未來三年內總計投入不超過港幣12億元,用於受託人根據《2018年股份獎勵計劃(2023年修訂版)》購買並持有股份,以作授予員工股份獎勵之用。於本公吿日期,概無根據《2018年股份獎勵計劃(2023年修訂版)》項下計劃規則及信託契據而購買股份的具體安排或時間表。公司將適時刊發關於股份獎勵計劃的進一步公吿及最新消息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.